BioMarin Pharmaceutical, Inc. (BMRN)
55.50
-1.74
(-3.04%)
USD |
NASDAQ |
Apr 02, 16:00
55.32
-0.18
(-0.32%)
Pre-Market: 09:04
BioMarin Pharmaceutical SG&A Expense (TTM) : 1.153B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 383.49M |
| Ionis Pharmaceuticals, Inc. | 393.68M |
| Mirum Pharmaceuticals, Inc. | 257.03M |
| Hims & Hers Health, Inc. | 1.192B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |